| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 14 |
| 1 | BEVACIZUMAB | 11 |
| 2 | SPIRONOLACTONE | 11 |
| 3 | ACETAMINOPHEN | 10 |
| 4 | ASPIRIN | 9 |
| 5 | ASPIRIN 325 MG | 9 |
| 6 | ASPIRIN 81 MG | 9 |
| 7 | ACETAMINOPHEN 500MG | 7 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 7 |
| 9 | EFAVIRENZ | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 2 | 0.0204 |
| 1 | NELFINAVIR MESYLATE | 3 | 0.0014 |
| 2 | MEBENDAZOLE | 1 | 0.0013 |
| 3 | DORZOLAMIDE HCL | 1 | 0.0009 |
| 4 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 5 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 6 | EFAVIRENZ | 7 | 0.0006 |
| 7 | ISOFLURANE | 1 | 0.0005 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 4 | 0.0005 |
| 9 | CERITINIB | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0003 |
| 2 | Anti-anginal [EPC] | 2 | 0.0002 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Bile Acid [EPC] | 3 | 0.0001 |
| 7 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 8 | Sulfone [EPC] | 1 | 0.0001 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0001 |